Legal & Regulatory
Federal Reserve signals faster but still slow path for rate rises
Federal Reserve officials nudged their expected path of interest rate increases higher on Wednesday, but did little to change the outlook for a long slow climb back up to normal monetary policy.
Activist investor Peltz wants DuPont to break up: WSJ
Activist investor Nelson Peltz's Trian Fund Management has called for a break up of DuPont (DD.N), arguing that the diversified chemicals company's overly complex and bloated corporate structure overburdens its seven business lines, the Wall Street Journal reported.
Fed could hint on rate-hike plans as it prepares for policy turn
The U.S. Federal Reserve on Wednesday could offer fresh clues on when it plans to begin lifting interest rates and how quickly it will move, as it prepares for a momentous policy turn after years of aggressive monetary stimulus.
Endo offers to buy Auxilium Pharma for about $2.2 billion
Specialty healthcare company Endo International Plc (ENDP.O) (ENL.TO) offered to buy Auxilium Pharmaceuticals Inc (AUXL.O) for about $2.2 billion in cash and stock to expand its men's healthcare products business.




